Novartis Foundation, a Basel, Switzerland-based healthcare solutions company, appointed four new members to its board of trustees.
Here are five things to know:
1. Joerg Reinhardt, PhD, is the chairman of the Novartis Board of Directors and was named the chairman of Novartis' board. He replaced Andrin Oswald, MD.
2. Professor Piot, director of the London School of Hygiene & Tropical Medicine, joined the board. He was the founding executive director of UNAIDS and co-discoverer of the Ebola virus.
3. The board also welcomed Rebecca Weintraub, MD, assistant professor at Harvard Medical School. Dr. Weintraub is an associate physician in the Division of Global Health Equity at Brigham and Women's Hospital.
4. Rainer Boehm of Novartis Pharmaceuticals also joined the board.
5. Novartis works to create healthcare models for poor populations internationally. They are trying to eradicate leprosy and malaria by interrupting transmission.
"The Novartis Foundation has been committed to improving healthcare for the poorest population for more than 35 years," said Dr. Reinhardt. "I am happy to contribute to the continuation of this important work…"
Recent articles:
7 things for ASC leaders to know for Monday — July 27, 2015
Dr. Adam Sise joins Eyecare Medical Group: 5 key notes
5 points on Laser Spine Institute's new president, David Pillsbury